Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors

Journal of Clinical Sleep Medicine

Volumn 8, Issue 6, 2012, Pages 643-648

  Walsh, Jessica A ^a   Duffin, Kristina Callis ^a   Crim, Julia ^a   Clegg, Daniel O ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Obstructive sleep apnea; Spondyloarthritis; TNF inhibitor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; QUALITY OF LIFE; SLEEP DISORDERED BREATHING; SPONDYLARTHRITIS; VETERAN;

ANTI-INFLAMMATORY AGENTS; COMORBIDITY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE; SPONDYLARTHROPATHIES; TUMOR NECROSIS FACTOR-ALPHA; UTAH;

EID: 84871374420     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.2254     Document Type: Article

References (40)

1. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5:136-43. (Pubitemid 351237871)
2. Deodhar A, Braun J, Inman RD, et al. Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebocontrolled trial. Arthritis Care Res (Hoboken) 2010;62:1266-71.
3. Heiberg T, Lie E, van der Heijde D, Kvien TK. Sleep problems are of higher priority for improvement for patients with ankylosing spondylitis than for patients with other inflammatory arthropathies. Ann Rheum Dis 2011;70:872-3.
4. Lee YC, Chibnik LB, Lu B, et al. The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2009;11:R160.
5. Erb N, Karokis D, Delamere JP, Cushley MJ, Kitas GD. Obstructive sleep apnoea as a cause of fatigue in ankylosing spondylitis. Ann Rheum Dis 2003;62:183-4. (Pubitemid 36135399)
6. Solak O, Fidan F, Dündar U, et al. The prevalence of obstructive sleep apnoea syndrome in ankylosing spondylitis patients. Rheumatology (Oxford) 2009;48:433-5.
7. Callis Duffin K, Wong B, Horn EJ, Krueger GG. Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol 2009;60:604-8.
8. Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients. Semin Cutan Med Surg 2010;29:10-5.
9. Yamamoto J, Okamoto Y, Shibuya E, Nishimura M, Kawakami Y. Obstructive sleep apnea syndrome induced by ossification of the anterior longitudinal ligament with ankylosing spondylitis. Nihon Kokyuki Gakkai Zasshi 2000;38:413-6.
10. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism 2011;60:1500-10.
11. Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology 2012;17:32-42.
12. Fuerderer S, Eysel-Gosepath K, Schröder U, Delank KS, Eysel PJ. Retro-pharyngeal obstruction in association with osteophytes of the cervical spine. Bone Joint Surg Br 2004;86:837-40. (Pubitemid 39173470)
13. Ryan S, Taylor CT, McNicholas WT.Predictors of elevated nuclear factor-kap-paB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006;174:824-30. (Pubitemid 44511665)
14. Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009;33:1195-205.
15. Kapsimalis F, Basta M, Varouchakis G, Gourgoulianis K, Vgontzas A, Kryger M. Cytokines and pathological sleep. Sleep Med 2008;9:603-14.
16. Herenius MM, Hoving JL, Sluiter JK, et al. Improvement of work ability, quality of life, and fatigue in patients with rheumatoid arthritis treated with adalimumab. J Occup Environ Med 2010;52:618-21.
17. Rudwaleit M, Gooch K, Michel B, et al. Adalimumab improves sleep and sleep quality in patients with active ankylosing spondylitis. J Rheumatol 2011;38:79-86.
18. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004;89:4409-13. (Pubitemid 39244447)
19. Edrees AF, Misra SN, Abdou NI. Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin Exp Rheumatol 2005;23:469-74. (Pubitemid 41447616)
20. Winkler G, Lakatos P, Salamon F, et al. Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabet Med 1999;16:207-11.
21. Braun J, Baraliakos X. Imaging of axial spondyloarthritis including ankylosing spondylitis. Ann Rheum Dis 2011;70 Suppl 1:i97-103.
22. Kent BD, Ryan S, McNicholas WT. Obstructive sleep apnea and inflammation: Relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 2011 Mar 23.[Epub ahead of print]
23. Kuhle S, Urschitz MS. Anti-inflammatory medications for obstructive sleep apnea in children. Cochrane Database Syst Rev 2011:CD007074.
24. Smith I, Lasserson TJ, Wright J. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006 19:CD003002.
25. Huston JM, Tracey KJ. The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med 2011;269:45-53.
26. Wang X, Yang Z, Xue B, Shi H. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance. Endocrinology 2011;152:836-46.
27. Hedner J, Kraiczi H, Peker Y, Murphy P. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med 2003;168:1246-51. (Pubitemid 37421845)
28. Mermigkis C, Bouloukaki I, Mermigkis D, et al. CRP evolution patter in CPAPtreated obstructive sleep apnea patients. Does gender play a role? Sleep Breath 2011 Sept 1. [Epub ahead of print]
29. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: Prevalence and severity. Am J Respir Crit Care Med 1998;157:144-8. (Pubitemid 28071275)
30. Sharafkhaneh A, Richardson P, Hirshkowitz M. Sleep apnea in a high risk population: a study of Veterans Health Administration beneficiaries. Sleep Med 2004;5:345-50. (Pubitemid 38842731)
31. Kreis P, Kripke DF, Ancoli-Israel S. Sleep apnea: a prospective study. West J Med 1983;139:171-3. (Pubitemid 13041983)
32. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39. (Pubitemid 34461732)
33. Sanner BM, Klewer J, Trumm A, Randerath W, Kreuzer I, Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J 2000;16:118-22. (Pubitemid 30480139)
34. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008;31:1071-8.
35. Jennum P, Kjellberg J. Health, social and economic consequences of sleepdisordered breathing: a controlled national study. Thorax 2011;66:560-6.
36. Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long-term compliance with continuous positive airway pressure. Thorax 2010;65:829-32.
37. Randerath WJ, Verbraecken J, Andreas S, et al. Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J 2011;37:1000-28.
38. Woodson BT. Non-pressure therapies for obstructive sleep apnea: surgery and oral appliances. Respir Care 2010;55:1314-21; discussion 1321.
39. Santos-Silva R, Sartori DE, Truksinas V, et al. Validation of a portable monitoring system for the diagnosis of obstructive sleep apnea syndrome. Sleep 2009;32:629-36.
40. Collop NA. Portable monitoring for the diagnosis of obstructive sleep apnea. Curr Opin Pulm Med 2008;14:525-9.